STOCK TITAN

Camp4 Therapeutics Corp. Stock Price, News & Analysis

CAMP Nasdaq

Welcome to our dedicated page for Camp4 Therapeutics news (Ticker: CAMP), a resource for investors and traders seeking the latest updates and insights on Camp4 Therapeutics stock.

CAMP4 Therapeutics Corp (NASDAQ: CAMP) delivers pioneering RNA-based therapies targeting genetic diseases through its innovative RAP Platform™. This page provides investors and researchers with verified updates on clinical developments, strategic partnerships, and regulatory milestones.

Access real-time announcements about CAMP4's progress in upregulating gene expression for CNS and liver disorders. Track key updates including clinical trial phases, FDA designations, and collaborative research initiatives with industry leaders like BioMarin.

All content undergoes rigorous verification to ensure compliance with financial reporting standards. Bookmark this page for centralized access to earnings reports, therapy pipeline advancements, and scientific publications related to regRNA modulation technologies.

Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced a partnership between its subsidiary LoJack Italia and Maldarizzi Automotive to enhance vehicle safety for 12,000 customers in southern Italy. Vehicles sold by Maldarizzi will feature LoJack Connect, which offers real-time diagnostics and alerts for maintenance issues, improving overall road safety. The collaboration aims to provide timely crash response, maintenance reminders, and stolen vehicle assistance. This agreement was highlighted during the 'Automotive Dealer Day Digital Edition' webinar held on September 16-17, 2020, focusing on reducing traffic accidents in Italy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) has announced the release date for its fiscal 2021 second quarter results, set for September 24, 2020, after the market closes. Following this, a conference call will be held at 4:30 PM ET to discuss the financial results, accessible via the company's website. A replay of the call will be available for 90 days. With over 20 million products installed worldwide and 1.3 million software subscribers, CalAmp continues to be a pioneer in the mobile connected economy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced significant upgrades to its Synovia Solutions fleet intelligence platform, enhancing its mobile application capabilities. The new features allow fleet operators to clock in/out and conduct trip inspections remotely, addressing customer needs due to COVID-19. The upgrades aim to streamline operations and improve safety by incorporating COVID-19 hygiene checks and wellness validation. Synovia serves over 1,000 fleet customers and has achieved a user-friendly app rating of 4.7 stars on the Apple App Store, enhancing its value proposition in the mobile connected economy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.51%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced the appointment of Kirsten Wolberg to its Board of Directors on August 26, 2020. Wolberg, currently serving as chief technology & operations officer at DocuSign, brings over 20 years of experience from companies like PayPal and Salesforce. Her expertise in technology management is seen as vital for CalAmp's corporate transformation and growth strategy. Both the Chair and CEO expressed confidence in her ability to contribute valuable insights to enhance shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.4%
Tags
none
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) appointed Amal M. Johnson as Chair of its Board of Directors, marking a significant leadership change as she replaces A.J. "Bert" Moyer. Johnson has served on the board for nearly seven years and is the first female Chair in the company's 39-year history. CEO Jeff Gardner expressed confidence in her ability to guide the company through growth and innovation, while Moyer commended her extensive experience in technology sectors. Johnson aims to drive continued growth and customer transformation in the mobile connected economy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
management
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP), a leader in mobile IoT technology, will participate in two virtual financial conferences. The Jefferies Industrials Conference is scheduled for August 6, 2020, featuring a fireside chat with Jeff Gardner, President and CEO, at 10:15 a.m. PT. The Canaccord Genuity Annual Growth Conference follows on August 12, 2020, with discussions by Gardner and CFO Kurt Binder at 11:00 a.m. PT. Live webcasts and archives will be available on the CalAmp website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
conferences
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) has officially appointed Jeff Gardner as its president and CEO, effective immediately, following his interim role since March 25, 2020. The board expressed confidence in Gardner's leadership during a pivotal transition toward becoming a SaaS solutions provider. Gardner emphasized the company's strong position to capitalize on its competitive advantages and the commitment of its talented team. CalAmp remains focused on innovating and meeting customer needs as it navigates current market conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
management
Rhea-AI Summary

LoJack, a brand of CalAmp (Nasdaq: CAMP), reported a significant 15% increase in auto theft recoveries in April 2020 compared to the same month in 2019. May 2020 continued this upward trend, showing an 11% increase over the previous year. Key states such as California, Colorado, and Washington State saw recovery increases of 35%, 20%, and 25%, respectively. The company emphasizes the need for vehicle protection during the pandemic and offers innovative solutions like the LoJack Stolen Vehicle Recovery System, which boasts a recovery rate exceeding 90% and has helped recover over $1 billion worth of vehicles in the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
covid-19

FAQ

What is the current stock price of Camp4 Therapeutics (CAMP)?

The current stock price of Camp4 Therapeutics (CAMP) is $1.39 as of June 17, 2025.

What is the market cap of Camp4 Therapeutics (CAMP)?

The market cap of Camp4 Therapeutics (CAMP) is approximately 36.7M.
Camp4 Therapeutics Corp.

Nasdaq:CAMP

CAMP Rankings

CAMP Stock Data

36.69M
11.81M
35.4%
56.97%
1.63%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE